-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EM6KHfEy1+ObKKIh8sWbfn5vUwv8tM1czeczBrUN+pgg5Tb1esbbu/5LdGDIaFAQ Wp9dV17Y5fOuGtQwPqMVXg== 0001144204-10-040634.txt : 20100802 0001144204-10-040634.hdr.sgml : 20100802 20100802132615 ACCESSION NUMBER: 0001144204-10-040634 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100727 FILED AS OF DATE: 20100802 DATE AS OF CHANGE: 20100802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Freitag Gregory Gene CENTRAL INDEX KEY: 0001492710 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21615 FILM NUMBER: 10983523 MAIL ADDRESS: STREET 1: 1407 S. KINGS HIGHWAY CITY: TEXARKANA STATE: TX ZIP: 75501 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRESSURE BIOSCIENCES INC CENTRAL INDEX KEY: 0000830656 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 042652826 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14 NORFOLK AVENUE CITY: SOUTH EASTON STATE: MA ZIP: 02375 BUSINESS PHONE: 5082301828 MAIL ADDRESS: STREET 1: 14 NORFOLK AVENUE CITY: SOUTH EASTON STATE: MA ZIP: 02375 FORMER COMPANY: FORMER CONFORMED NAME: BOSTON BIOMEDICA INC DATE OF NAME CHANGE: 19960812 3 1 form316042_080210132555-.xml X0203 3 2010-07-27 0 0000830656 PRESSURE BIOSCIENCES INC PBIO 0001492710 Freitag Gregory Gene 909 KENWOOD PARKWAY MINNEAPOLIS MN US 55403 1 0 0 0 COMMON STOCK 216 D SERIES B CONVERTIBLE PREFERRED STOCK 0 2009-11-18 COMMON STOCK, PAR VALUE $.01 PER SHARE 26640 D SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE WARRANT 23.8 2009-11-18 2011-08-12 COMMON STOCK, PAR VALUE $.01 26640 D The terms of the Series B Convertible Preferred Stock contain a limitation on conversion which prevents the Reporting Person from converting shares of Series B Convertible Preferred Stock into shares of Common Stock if, after giving effect to the conversion, the Reporting Person would beneficially own more than 4.99% of the outstanding shares of Common Stock. The Reporting Person may elect to increase this limitation to 9.99%, 14.99% or 19.99%, upon not less than 61 days prior written notice to the Company. The Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest in such securities. The Series B Convertible Preferred Stock Warrants contain a limitation on exercise which prevents the Reporting Person from exercising any Warrants if, after giving effect to the exercise, the Reporting Person would beneficially own more than 4.99% of the outstanding shares of Common Stock. The Reporting Person may elect to increase this limitation to 9.99%, 14.99% or 19.99%, upon not less than 61 days prior written notice to the Company. The Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest in such securities. The Series B Convertible Preferred Stock has no expiration date. Richard T. Schumacher, Attorney in Fact 2010-08-02 -----END PRIVACY-ENHANCED MESSAGE-----